Dna X (SONM) Receivables - Net (2018 - 2025)
Dna X (SONM) has disclosed Receivables - Net for 8 consecutive years, with $3.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net fell 38.51% year-over-year to $3.5 million, compared with a TTM value of $3.5 million through Sep 2025, down 38.51%, and an annual FY2024 reading of $6.9 million, down 72.71% over the prior year.
- Receivables - Net was $3.5 million for Q3 2025 at Dna X, down from $5.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $32.0 million in Q3 2023 and bottomed at $3.5 million in Q3 2025.
- Average Receivables - Net over 5 years is $12.9 million, with a median of $10.4 million recorded in 2022.
- The sharpest move saw Receivables - Net skyrocketed 341.34% in 2023, then tumbled 82.21% in 2024.
- Year by year, Receivables - Net stood at $10.8 million in 2021, then surged by 108.7% to $22.5 million in 2022, then grew by 12.23% to $25.3 million in 2023, then crashed by 72.71% to $6.9 million in 2024, then tumbled by 49.35% to $3.5 million in 2025.
- Business Quant data shows Receivables - Net for SONM at $3.5 million in Q3 2025, $5.6 million in Q2 2025, and $4.8 million in Q1 2025.